1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Imatinib Mesylate Tablets Market Size 2018-2029 2.1.2 Imatinib Mesylate Tablets Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 Imatinib Mesylate Tablets Segment by Type 2.2.1 100 mg 2.2.2 400 mg 2.3 Imatinib Mesylate Tablets Market Size by Type 2.3.1 Imatinib Mesylate Tablets Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global Imatinib Mesylate Tablets Market Size Market Share by Type (2018-2023) 2.4 Imatinib Mesylate Tablets Segment by Application 2.4.1 Hospital 2.4.2 Clinics 2.5 Imatinib Mesylate Tablets Market Size by Application 2.5.1 Imatinib Mesylate Tablets Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global Imatinib Mesylate Tablets Market Size Market Share by Application (2018-2023) 3 Imatinib Mesylate Tablets Market Size by Player 3.1 Imatinib Mesylate Tablets Market Size Market Share by Players 3.1.1 Global Imatinib Mesylate Tablets Revenue by Players (2018-2023) 3.1.2 Global Imatinib Mesylate Tablets Revenue Market Share by Players (2018-2023) 3.2 Global Imatinib Mesylate Tablets Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Imatinib Mesylate Tablets by Regions 4.1 Imatinib Mesylate Tablets Market Size by Regions (2018-2023) 4.2 Americas Imatinib Mesylate Tablets Market Size Growth (2018-2023) 4.3 APAC Imatinib Mesylate Tablets Market Size Growth (2018-2023) 4.4 Europe Imatinib Mesylate Tablets Market Size Growth (2018-2023) 4.5 Middle East & Africa Imatinib Mesylate Tablets Market Size Growth (2018-2023) 5 Americas 5.1 Americas Imatinib Mesylate Tablets Market Size by Country (2018-2023) 5.2 Americas Imatinib Mesylate Tablets Market Size by Type (2018-2023) 5.3 Americas Imatinib Mesylate Tablets Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Imatinib Mesylate Tablets Market Size by Region (2018-2023) 6.2 APAC Imatinib Mesylate Tablets Market Size by Type (2018-2023) 6.3 APAC Imatinib Mesylate Tablets Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Imatinib Mesylate Tablets by Country (2018-2023) 7.2 Europe Imatinib Mesylate Tablets Market Size by Type (2018-2023) 7.3 Europe Imatinib Mesylate Tablets Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Imatinib Mesylate Tablets by Region (2018-2023) 8.2 Middle East & Africa Imatinib Mesylate Tablets Market Size by Type (2018-2023) 8.3 Middle East & Africa Imatinib Mesylate Tablets Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Imatinib Mesylate Tablets Market Forecast 10.1 Global Imatinib Mesylate Tablets Forecast by Regions (2024-2029) 10.1.1 Global Imatinib Mesylate Tablets Forecast by Regions (2024-2029) 10.1.2 Americas Imatinib Mesylate Tablets Forecast 10.1.3 APAC Imatinib Mesylate Tablets Forecast 10.1.4 Europe Imatinib Mesylate Tablets Forecast 10.1.5 Middle East & Africa Imatinib Mesylate Tablets Forecast 10.2 Americas Imatinib Mesylate Tablets Forecast by Country (2024-2029) 10.2.1 United States Imatinib Mesylate Tablets Market Forecast 10.2.2 Canada Imatinib Mesylate Tablets Market Forecast 10.2.3 Mexico Imatinib Mesylate Tablets Market Forecast 10.2.4 Brazil Imatinib Mesylate Tablets Market Forecast 10.3 APAC Imatinib Mesylate Tablets Forecast by Region (2024-2029) 10.3.1 China Imatinib Mesylate Tablets Market Forecast 10.3.2 Japan Imatinib Mesylate Tablets Market Forecast 10.3.3 Korea Imatinib Mesylate Tablets Market Forecast 10.3.4 Southeast Asia Imatinib Mesylate Tablets Market Forecast 10.3.5 India Imatinib Mesylate Tablets Market Forecast 10.3.6 Australia Imatinib Mesylate Tablets Market Forecast 10.4 Europe Imatinib Mesylate Tablets Forecast by Country (2024-2029) 10.4.1 Germany Imatinib Mesylate Tablets Market Forecast 10.4.2 France Imatinib Mesylate Tablets Market Forecast 10.4.3 UK Imatinib Mesylate Tablets Market Forecast 10.4.4 Italy Imatinib Mesylate Tablets Market Forecast 10.4.5 Russia Imatinib Mesylate Tablets Market Forecast 10.5 Middle East & Africa Imatinib Mesylate Tablets Forecast by Region (2024-2029) 10.5.1 Egypt Imatinib Mesylate Tablets Market Forecast 10.5.2 South Africa Imatinib Mesylate Tablets Market Forecast 10.5.3 Israel Imatinib Mesylate Tablets Market Forecast 10.5.4 Turkey Imatinib Mesylate Tablets Market Forecast 10.5.5 GCC Countries Imatinib Mesylate Tablets Market Forecast 10.6 Global Imatinib Mesylate Tablets Forecast by Type (2024-2029) 10.7 Global Imatinib Mesylate Tablets Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 Teva Pharmaceuticals 11.1.1 Teva Pharmaceuticals Company Information 11.1.2 Teva Pharmaceuticals Imatinib Mesylate Tablets Product Offered 11.1.3 Teva Pharmaceuticals Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 Teva Pharmaceuticals Main Business Overview 11.1.5 Teva Pharmaceuticals Latest Developments 11.2 Hikma Pharmaceuticals 11.2.1 Hikma Pharmaceuticals Company Information 11.2.2 Hikma Pharmaceuticals Imatinib Mesylate Tablets Product Offered 11.2.3 Hikma Pharmaceuticals Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 Hikma Pharmaceuticals Main Business Overview 11.2.5 Hikma Pharmaceuticals Latest Developments 11.3 Apotex Inc 11.3.1 Apotex Inc Company Information 11.3.2 Apotex Inc Imatinib Mesylate Tablets Product Offered 11.3.3 Apotex Inc Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 Apotex Inc Main Business Overview 11.3.5 Apotex Inc Latest Developments 11.4 Sun Pharmaceutical Industries 11.4.1 Sun Pharmaceutical Industries Company Information 11.4.2 Sun Pharmaceutical Industries Imatinib Mesylate Tablets Product Offered 11.4.3 Sun Pharmaceutical Industries Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 Sun Pharmaceutical Industries Main Business Overview 11.4.5 Sun Pharmaceutical Industries Latest Developments 11.5 Lupin Limited 11.5.1 Lupin Limited Company Information 11.5.2 Lupin Limited Imatinib Mesylate Tablets Product Offered 11.5.3 Lupin Limited Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 Lupin Limited Main Business Overview 11.5.5 Lupin Limited Latest Developments 11.6 Natco Pharma 11.6.1 Natco Pharma Company Information 11.6.2 Natco Pharma Imatinib Mesylate Tablets Product Offered 11.6.3 Natco Pharma Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 Natco Pharma Main Business Overview 11.6.5 Natco Pharma Latest Developments 11.7 Getwell Oncology 11.7.1 Getwell Oncology Company Information 11.7.2 Getwell Oncology Imatinib Mesylate Tablets Product Offered 11.7.3 Getwell Oncology Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 Getwell Oncology Main Business Overview 11.7.5 Getwell Oncology Latest Developments 12 Research Findings and Conclusion

List of Tables Table 1. Imatinib Mesylate Tablets Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of 100 mg Table 3. Major Players of 400 mg Table 4. Imatinib Mesylate Tablets Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 5. Global Imatinib Mesylate Tablets Market Size by Type (2018-2023) & ($ Millions) Table 6. Global Imatinib Mesylate Tablets Market Size Market Share by Type (2018-2023) Table 7. Imatinib Mesylate Tablets Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 8. Global Imatinib Mesylate Tablets Market Size by Application (2018-2023) & ($ Millions) Table 9. Global Imatinib Mesylate Tablets Market Size Market Share by Application (2018-2023) Table 10. Global Imatinib Mesylate Tablets Revenue by Players (2018-2023) & ($ Millions) Table 11. Global Imatinib Mesylate Tablets Revenue Market Share by Player (2018-2023) Table 12. Imatinib Mesylate Tablets Key Players Head office and Products Offered Table 13. Imatinib Mesylate Tablets Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Imatinib Mesylate Tablets Market Size by Regions 2018-2023 & ($ Millions) Table 17. Global Imatinib Mesylate Tablets Market Size Market Share by Regions (2018-2023) Table 18. Global Imatinib Mesylate Tablets Revenue by Country/Region (2018-2023) & ($ millions) Table 19. Global Imatinib Mesylate Tablets Revenue Market Share by Country/Region (2018-2023) Table 20. Americas Imatinib Mesylate Tablets Market Size by Country (2018-2023) & ($ Millions) Table 21. Americas Imatinib Mesylate Tablets Market Size Market Share by Country (2018-2023) Table 22. Americas Imatinib Mesylate Tablets Market Size by Type (2018-2023) & ($ Millions) Table 23. Americas Imatinib Mesylate Tablets Market Size Market Share by Type (2018-2023) Table 24. Americas Imatinib Mesylate Tablets Market Size by Application (2018-2023) & ($ Millions) Table 25. Americas Imatinib Mesylate Tablets Market Size Market Share by Application (2018-2023) Table 26. APAC Imatinib Mesylate Tablets Market Size by Region (2018-2023) & ($ Millions) Table 27. APAC Imatinib Mesylate Tablets Market Size Market Share by Region (2018-2023) Table 28. APAC Imatinib Mesylate Tablets Market Size by Type (2018-2023) & ($ Millions) Table 29. APAC Imatinib Mesylate Tablets Market Size Market Share by Type (2018-2023) Table 30. APAC Imatinib Mesylate Tablets Market Size by Application (2018-2023) & ($ Millions) Table 31. APAC Imatinib Mesylate Tablets Market Size Market Share by Application (2018-2023) Table 32. Europe Imatinib Mesylate Tablets Market Size by Country (2018-2023) & ($ Millions) Table 33. Europe Imatinib Mesylate Tablets Market Size Market Share by Country (2018-2023) Table 34. Europe Imatinib Mesylate Tablets Market Size by Type (2018-2023) & ($ Millions) Table 35. Europe Imatinib Mesylate Tablets Market Size Market Share by Type (2018-2023) Table 36. Europe Imatinib Mesylate Tablets Market Size by Application (2018-2023) & ($ Millions) Table 37. Europe Imatinib Mesylate Tablets Market Size Market Share by Application (2018-2023) Table 38. Middle East & Africa Imatinib Mesylate Tablets Market Size by Region (2018-2023) & ($ Millions) Table 39. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Region (2018-2023) Table 40. Middle East & Africa Imatinib Mesylate Tablets Market Size by Type (2018-2023) & ($ Millions) Table 41. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Type (2018-2023) Table 42. Middle East & Africa Imatinib Mesylate Tablets Market Size by Application (2018-2023) & ($ Millions) Table 43. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Application (2018-2023) Table 44. Key Market Drivers & Growth Opportunities of Imatinib Mesylate Tablets Table 45. Key Market Challenges & Risks of Imatinib Mesylate Tablets Table 46. Key Industry Trends of Imatinib Mesylate Tablets Table 47. Global Imatinib Mesylate Tablets Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 48. Global Imatinib Mesylate Tablets Market Size Market Share Forecast by Regions (2024-2029) Table 49. Global Imatinib Mesylate Tablets Market Size Forecast by Type (2024-2029) & ($ Millions) Table 50. Global Imatinib Mesylate Tablets Market Size Forecast by Application (2024-2029) & ($ Millions) Table 51. Teva Pharmaceuticals Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors Table 52. Teva Pharmaceuticals Imatinib Mesylate Tablets Product Offered Table 53. Teva Pharmaceuticals Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 54. Teva Pharmaceuticals Main Business Table 55. Teva Pharmaceuticals Latest Developments Table 56. Hikma Pharmaceuticals Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors Table 57. Hikma Pharmaceuticals Imatinib Mesylate Tablets Product Offered Table 58. Hikma Pharmaceuticals Main Business Table 59. Hikma Pharmaceuticals Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 60. Hikma Pharmaceuticals Latest Developments Table 61. Apotex Inc Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors Table 62. Apotex Inc Imatinib Mesylate Tablets Product Offered Table 63. Apotex Inc Main Business Table 64. Apotex Inc Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 65. Apotex Inc Latest Developments Table 66. Sun Pharmaceutical Industries Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors Table 67. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Product Offered Table 68. Sun Pharmaceutical Industries Main Business Table 69. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 70. Sun Pharmaceutical Industries Latest Developments Table 71. Lupin Limited Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors Table 72. Lupin Limited Imatinib Mesylate Tablets Product Offered Table 73. Lupin Limited Main Business Table 74. Lupin Limited Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 75. Lupin Limited Latest Developments Table 76. Natco Pharma Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors Table 77. Natco Pharma Imatinib Mesylate Tablets Product Offered Table 78. Natco Pharma Main Business Table 79. Natco Pharma Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 80. Natco Pharma Latest Developments Table 81. Getwell Oncology Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors Table 82. Getwell Oncology Imatinib Mesylate Tablets Product Offered Table 83. Getwell Oncology Main Business Table 84. Getwell Oncology Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 85. Getwell Oncology Latest Developments List of Figures Figure 1. Imatinib Mesylate Tablets Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Imatinib Mesylate Tablets Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. Imatinib Mesylate Tablets Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. Imatinib Mesylate Tablets Sales Market Share by Country/Region (2022) Figure 8. Imatinib Mesylate Tablets Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global Imatinib Mesylate Tablets Market Size Market Share by Type in 2022 Figure 10. Imatinib Mesylate Tablets in Hospital Figure 11. Global Imatinib Mesylate Tablets Market: Hospital (2018-2023) & ($ Millions) Figure 12. Imatinib Mesylate Tablets in Clinics Figure 13. Global Imatinib Mesylate Tablets Market: Clinics (2018-2023) & ($ Millions) Figure 14. Global Imatinib Mesylate Tablets Market Size Market Share by Application in 2022 Figure 15. Global Imatinib Mesylate Tablets Revenue Market Share by Player in 2022 Figure 16. Global Imatinib Mesylate Tablets Market Size Market Share by Regions (2018-2023) Figure 17. Americas Imatinib Mesylate Tablets Market Size 2018-2023 ($ Millions) Figure 18. APAC Imatinib Mesylate Tablets Market Size 2018-2023 ($ Millions) Figure 19. Europe Imatinib Mesylate Tablets Market Size 2018-2023 ($ Millions) Figure 20. Middle East & Africa Imatinib Mesylate Tablets Market Size 2018-2023 ($ Millions) Figure 21. Americas Imatinib Mesylate Tablets Value Market Share by Country in 2022 Figure 22. United States Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 23. Canada Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 24. Mexico Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 25. Brazil Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 26. APAC Imatinib Mesylate Tablets Market Size Market Share by Region in 2022 Figure 27. APAC Imatinib Mesylate Tablets Market Size Market Share by Type in 2022 Figure 28. APAC Imatinib Mesylate Tablets Market Size Market Share by Application in 2022 Figure 29. China Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 30. Japan Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 31. Korea Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 32. Southeast Asia Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 33. India Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 34. Australia Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 35. Europe Imatinib Mesylate Tablets Market Size Market Share by Country in 2022 Figure 36. Europe Imatinib Mesylate Tablets Market Size Market Share by Type (2018-2023) Figure 37. Europe Imatinib Mesylate Tablets Market Size Market Share by Application (2018-2023) Figure 38. Germany Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 39. France Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 40. UK Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 41. Italy Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 42. Russia Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 43. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Region (2018-2023) Figure 44. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Type (2018-2023) Figure 45. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Application (2018-2023) Figure 46. Egypt Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 47. South Africa Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 48. Israel Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 49. Turkey Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 50. GCC Country Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions) Figure 51. Americas Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 52. APAC Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 53. Europe Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 54. Middle East & Africa Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 55. United States Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 56. Canada Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 57. Mexico Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 58. Brazil Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 59. China Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 60. Japan Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 61. Korea Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 62. Southeast Asia Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 63. India Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 64. Australia Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 65. Germany Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 66. France Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 67. UK Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 68. Italy Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 69. Russia Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 70. Spain Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 71. Egypt Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 72. South Africa Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 73. Israel Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 74. Turkey Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 75. GCC Countries Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions) Figure 76. Global Imatinib Mesylate Tablets Market Size Market Share Forecast by Type (2024-2029) Figure 77. Global Imatinib Mesylate Tablets Market Size Market Share Forecast by Application (2024-2029)